Get access to more insightful information
By signing up to Upstox today
WhiteOak Capital Pharma and Healthcare Fund Direct growth
Equity • Healthcare • Direct growth
Insufficient fund history to generate its report card
CAGR
₹1,000 invested for 5 years
Fund Info
Equity
Healthcare
Direct growth
Launched On
06 Feb 2024
2.3 years ago
Lock-in Period
No lock-in
NAV
as of 13 May 2026
₹15.39
+0.2279% (0.10)
AUM
₹492 Cr
Expense ratio
0.67%
Benchmark
Fund Plan
Tax info and exit load
Taxes
Units held less than 1Y
20.00%
Units held more than 1Y
12.50%
Exit Load
If units sold anytime
0%
Distribution
Asset split
Market capital
Equity98.70%
Cash1.30%
What's in this fund?
Sectors
Holdings
Healthcare
Basic Materials
Fund House
WhiteOak
Inc: 16 Jan 2019 • Total AUM: ₹32,132 Cr • Rank #25WhiteOak Capital Mutual Fund, started in 2021, has WhiteOak Capital group as its sponsors. The fund house is headed by Aashish P. Somaiyaa as the CEO. As of 31 March 2024, it has an AUM of ₹10,327 Cr.
Fund Managers
Piyush Baranwal
Experience: 7.31 yrs • Total AUM: 1,33,341 Cr
Ramesh Mantri
Experience: 3.76 yrs • Total AUM: 1,15,091 Cr
Trupti Agrawal
Experience: 3.74 yrs • Total AUM: 1,13,178 Cr
Dheeresh Pathak
Experience: 2.25 yrs • Total AUM: 1,13,178 Cr
Ashish Agrawal
Experience: yrs • Total AUM: 1,12,728 Cr
Risk
Category risk
Very high
As provided by the fund house document, this risk is specific to this fund category (Equity). To know the risk of this fund particularly, check 'Risk vs Category'.
Disclaimer: Top rated funds do not constitute any advice. Research data is powered by Morningstar. Please read the offer documents carefully before investing. Upstox shall not accept any liability arising out of your investments.